BMI1 and glioma: For example, Bmi-1 inhibition in colorectal cancer [12] and combined suppression of Bmi-1 and enhancer of zeste 2 Polycomb repressive complex 2 subunit (EZH2) expression in glioma [15] effectively eliminated cancer stem-like cells, thereby achieving an ideal anticancer efficacy.